Investors / United States / BEVC
BEVC
Venture capital · Berkeley, CA, United States · North America
BEVC is an early-stage venture capital firm founded by scientists and entrepreneurs that invests in companies translating academic research into commercial technology. It is based in Berkeley and works closely with the Berkeley and UCSF research ecosystems, providing technical, strategic and operational support to founders.
Invests inHealthcare & BiotechClimate & Energy
In its own wordshealthenergymaterialsdeep techartificial intelligencelife sciences
Your fit with BEVC
Three questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBEVC lists 12 companies on its own site, 10 of them checked. It is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Pre-seed, 50% of the 2 companies where the round it came in at is known. Its largest themes are Healthcare & Biotech (70%), Climate & Energy (20%) and Industrial & Manufacturing (10%). 100% of its 9 companies with a known country are based in United States. It shares the most portfolio companies with KdT Ventures, 10VC and AP Ventures.
Counts come from funding rounds that name BEVC, complete from mid-2025: earlier rounds appear only when they were reported later. Reports often leave out co-leads, so a firm may have led more rounds than shown. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not BEVC's whole history. Rounds on record name 3 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage it came in at · n=2Counted only where the round is where it came in: a pre-seed or seed round, or a later round after the company raised without it.
Show as a table
| Value | |
|---|---|
| Pre-seed | 50% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 21st | 10 companies |
| Recent activity | 71st | 3 rounds in 12 months |
| Early stage | 13th | 50% of 2 known entries at pre-seed or seed |
| Evidence | 75th | 10% of companies confirmed by a round |
| Sector focus | 84th | 70% of companies in its largest theme |
| Reach | 10th | 1 country, from 9 companies with a known country |
Investment themes
share of its 10 companies with a theme; a company can have twoThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 70% | 17% |
| Climate & Energy | 20% | 7% |
| Industrial & Manufacturing | 10% | 3% |
| AI & Machine Learning | 10% | 13% |
| Advanced Materials & Chemicals | 10% | 2% |
Invests in the same rounds as
named on the same funding round, and both list the company on their own siteShow as a table
| Share | |
|---|---|
| Abingworth | 1 |
| Pivotal Life Sciences | 1 |
| SR One | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers990%
- No longer answers00%
- Points to another company110%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Shared portfolio network
firms that back the same companies, and what they share with each otherCompare BEVC head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with BEVC| Date | Company | Stage |
|---|---|---|
| 18 Nov 2026 | Series C+ | |
| 26 Aug 2026 | Pre-Seed Led | |
| 17 Dec 2025 | Series A |
Round details for BEVC
Amounts, full round histories and every co-investor in BEVC's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Addition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases | Healthcare & Biotech | Dec 2025Series A | Page + round | |
Industrial & ManufacturingAI & Machine Learning | Portfolio page | |||
| Ansa Biotechnologies synthesizes custom DNA sequences for its customers. | Healthcare & Biotech | Nov 2026Series C+ | Funding round | |
| Dextera Biosciences is pioneering a new class of therapeutics—dexabodies—built entirely from D-amino acids to overcome the key limitations of existing drug modalities | Healthcare & Biotech | Portfolio page | ||
| Insamo discovers drugs for challenging diseases using a platform that designs, synthesizes, and tests cyclic-peptides | Healthcare & Biotech | Portfolio page | ||
| Khemia Metals makes lighter, cheaper, and more sustainable batteries using earth-abundant alloys. | Climate & EnergyAdvanced Materials & Chemicals | Portfolio page | ||
| Montara Therapeutics is developing safer, more efficacious therapies to improve the lives of patients with neurological diseases. | Healthcare & Biotech | Portfolio page | ||
| The company is developing a test to detect endometrial cancer from a simple, non-invasive vaginal swab. | Healthcare & Biotech | Portfolio page | ||
| Radar Therapeutics is pioneering a new treatment modality: precision-expressed mRNA-based therapeutics. | Healthcare & Biotech | Portfolio page | ||
| Teragen Energy builds advanced fuel cell systems to bring fast, reliable, affordable, clean power where it's needed most. | Climate & Energy | Aug 2026Pre-Seed | Funding round |
About this data
site last read 19 Nov 2026- Site
- bevc.com
- Last read
- 19 Nov 2026
- Watching since
- 19 Nov 2026
- Rounds since
- 17 Dec 2025
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BEVC's profile as data
Pull BEVC's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/bevc.com
# also
GET /v1/firms/bevc.com/portfolio
GET /v1/firms/bevc.com/coinvestors
GET /v1/firms/bevc.com/news